Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
---|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | ||||
5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.88 | -9.57 | -9.29 | 47.47% | CHEMBL420475 |
5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -9.15 | -10.26 | N/A | 53.52% | CHEMBL1774062 |
5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -9.16 | -9.57 | -9.75 | 52.06% | CHEMBL203025 |
5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -9.26 | -9.23 | N/A | 52.06% | CHEMBL203025 |
AA1R_HUMAN | adenosine A1 receptor | -9.34 | -9.55 | -6.62 | 44.04% | CHEMBL242633 |
AA2AR_HUMAN | adenosine A2a receptor | -9.16 | -9.50 | -8.81 | 41.91% | CHEMBL1950664 |
ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -10.78 | -10.26 | -12.37 | 49.30% | CHEMBL223443 |
ACE_HUMAN | angiotensin I converting enzyme | -8.97 | -8.88 | -8.19 | 53.33% | CHEMBL44077 |
ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -7.39 | N/A | N/A | 46.64% | CHEMBL386114 |
ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.67 | -6.58 | -4.46 | N/A | N/A |
ACM1_HUMAN | cholinergic receptor muscarinic 1 | -7.38 | 1.77 | N/A | 54.50% | CHEMBL3310802 |
ACM4_HUMAN | cholinergic receptor muscarinic 4 | -8.56 | -6.06 | N/A | 54.50% | CHEMBL3310802 |
ADRB2_HUMAN | adrenoceptor beta 2 | -7.53 | -10.17 | -10.37 | 44.92% | CHEMBL1078695 |
AGTR2_HUMAN | angiotensin II receptor type 2 | -9.01 | -8.62 | -8.54 | 46.22% | CHEMBL406907 |
ALDR_HUMAN | aldo-keto reductase family 1 member B | -9.10 | -9.20 | -8.32 | 38.61% | CHEMBL294612 |
AMPN_HUMAN | alanyl aminopeptidase, membrane | -9.22 | -9.40 | -8.27 | 38.99% | CHEMBL261120 |
AOFA_HUMAN | monoamine oxidase A | -10.63 | -10.59 | -10.95 | 41.30% | CHEMBL2333929 |
AOFB_HUMAN | monoamine oxidase B | -10.45 | -11.14 | -11.04 | 41.30% | CHEMBL2333929 |
BACE1_HUMAN | beta-secretase 1 | -7.96 | -7.88 | -8.60 | 48.82% | CHEMBL1934295 |
CAH2_HUMAN | carbonic anhydrase 2 | -7.93 | -7.72 | -7.60 | 35.22% | CHEMBL52550 |
CASP1_HUMAN | caspase 1 | -6.89 | -6.69 | -6.78 | 47.91% | CHEMBL114791 |
CDK5_HUMAN | cyclin dependent kinase 5 | -8.02 | -8.13 | -8.05 | 47.67% | CHEMBL1983630 |
CHLE_HUMAN | butyrylcholinesterase | -9.36 | -9.83 | -9.16 | 49.30% | CHEMBL223443 |
CNR1_HUMAN | cannabinoid receptor 1 | -7.96 | -8.27 | -10.53 | 56.17% | CHEMBL1082650 |
CNR2_HUMAN | cannabinoid receptor 2 | -9.86 | -9.77 | N/A | 54.70% | CHEMBL1082330 |
COLI_HUMAN | proopiomelanocortin | -9.85 | -9.71 | -8.51 | N/A | N/A |
COMT_HUMAN | catechol-O-methyltransferase | -6.44 | -6.94 | -6.29 | 32.03% | CHEMBL3425740 |
CRP_HUMAN | C-reactive protein | -6.20 | -6.51 | N/A | N/A | N/A |
CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -4.60 | N/A | N/A | 34.13% | CHEMBL556862 |
CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -9.19 | -6.96 | -8.46 | 41.56% | CHEMBL1650560 |
DRD2_HUMAN | dopamine receptor D2 | -9.73 | N/A | N/A | 53.85% | CHEMBL2059310 |
DRD3_HUMAN | dopamine receptor D3 | -9.49 | N/A | N/A | 47.70% | CHEMBL2165119 |
DRD4_HUMAN | dopamine receptor D4 | -10.29 | -10.62 | N/A | 47.70% | CHEMBL2165119 |
EDN1_HUMAN | endothelin 1 | -8.59 | N/A | N/A | N/A | N/A |
ESR1_HUMAN | estrogen receptor 1 | -8.03 | -8.35 | -8.70 | 42.25% | CHEMBL4075189 |
FABP5_HUMAN | fatty acid binding protein 5 | -8.91 | -7.34 | -7.07 | 47.14% | CHEMBL3971182 |
FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -8.37 | N/A | N/A | 41.97% | CHEMBL1998121 |
GLRA3_HUMAN | glycine receptor alpha 3 | -8.88 | -9.22 | -9.21 | 40.08% | CHEMBL4070615 |
GLRA3_HUMAN | glycine receptor alpha 3 | -9.76 | N/A | N/A | 40.08% | CHEMBL4070615 |
GRM5_HUMAN | glutamate metabotropic receptor 5 | -6.22 | -4.21 | -4.49 | 49.03% | CHEMBL3925795 |
HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.60 | -7.18 | -7.72 | 38.94% | CHEMBL3425953 |
HRH1_HUMAN | histamine receptor H1 | -5.91 | N/A | N/A | 47.76% | CHEMBL2158834 |
HYES_HUMAN | epoxide hydrolase 2 | -8.99 | -8.97 | -9.00 | 51.79% | CHEMBL1078337 |
IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -8.12 | N/A | N/A | 45.45% | CHEMBL3823257 |
MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -9.52 | -7.98 | N/A | 41.77% | CHEMBL1823872 |
MIF_HUMAN | macrophage migration inhibitory factor | -7.31 | -8.88 | -8.04 | 26.78% | CHEMBL554271 |
MK01_HUMAN | mitogen-activated protein kinase 1 | -8.69 | -8.20 | -7.56 | 44.30% | CHEMBL3921309 |
MK03_HUMAN | mitogen-activated protein kinase 3 | -8.67 | -8.40 | -8.51 | 31.37% | CHEMBL213618 |
MTOR_HUMAN | mechanistic target of rapamycin kinase | -9.42 | -10.47 | -9.22 | 44.89% | CHEMBL3693557 |
NEP_HUMAN | membrane metalloendopeptidase | -8.25 | -8.71 | -7.99 | 46.15% | CHEMBL4061434 |
NK1R_HUMAN | tachykinin receptor 1 | -8.96 | -9.00 | -8.41 | 48.00% | CHEMBL2369607 |
NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.51 | -8.27 | -8.06 | 17.83% | CHEMBL2333945 |
NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -8.98 | -9.43 | -7.37 | 39.06% | CHEMBL218017 |
NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.44 | -8.25 | -8.06 | 33.88% | CHEMBL354003 |
NOS1_HUMAN | nitric oxide synthase 1 | -9.37 | -9.70 | -10.43 | 40.98% | CHEMBL3407814 |
NOS2_HUMAN | nitric oxide synthase 2 | -9.59 | -10.42 | -9.89 | 38.24% | CHEMBL112866 |
NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -8.78 | -8.60 | -8.38 | 47.67% | CHEMBL1983630 |
OPRD_HUMAN | opioid receptor delta 1 | -8.23 | -7.28 | -7.72 | 49.19% | CHEMBL521830 |
OPRK_HUMAN | opioid receptor kappa 1 | -9.88 | -8.95 | -9.62 | 48.96% | CHEMBL198867 |
OPRM_MOUSE | Mu-type opioid receptor | -9.17 | -8.36 | N/A | 43.75% | CHEMBL2147903 |
OPRX_HUMAN | opioid related nociceptin receptor 1 | -7.77 | -7.98 | -8.74 | 48.96% | CHEMBL198867 |
P2RX3_HUMAN | purinergic receptor P2X 3 | -6.46 | -5.89 | -6.66 | 51.05% | CHEMBL3679789 |
P2Y12_HUMAN | purinergic receptor P2Y12 | -8.53 | -7.47 | -9.70 | 47.60% | CHEMBL2402268 |
PAR1_HUMAN | coagulation factor II thrombin receptor | -9.01 | N/A | N/A | 41.88% | CHEMBL3658403 |
PDE4B_HUMAN | phosphodiesterase 4B | -9.24 | -9.41 | -9.16 | 43.37% | CHEMBL1257421 |
PDE5A_HUMAN | phosphodiesterase 5A | -8.62 | -9.87 | -9.59 | 38.67% | CHEMBL25616 |
PERM_HUMAN | myeloperoxidase | -9.12 | -8.49 | -8.59 | 37.04% | CHEMBL2347029 |
PGH1_SHEEP | Prostaglandin G/H synthase 1 | -6.83 | -9.85 | -7.74 | 40.09% | CHEMBL24798 |
PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -2.91 | -5.21 | -7.99 | 40.81% | CHEMBL95469 |
PPAP_HUMAN | acid phosphatase 3 | -8.51 | N/A | N/A | 14.16% | CHEMBL507996 |
PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -8.00 | -7.73 | -8.38 | 42.86% | CHEMBL181159 |
PRGR_HUMAN | progesterone receptor | -8.59 | -8.00 | -8.96 | 44.50% | CHEMBL324499 |
PTGES_HUMAN | prostaglandin E synthase | -7.80 | N/A | N/A | 52.88% | CHEMBL4101413 |
SC6A4_HUMAN | solute carrier family 6 member 4 | -10.00 | -10.24 | -9.64 | 49.20% | CHEMBL1224318 |
SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -7.84 | N/A | N/A | 51.82% | CHEMBL1779920 |
TLR4_HUMAN | toll like receptor 4 | -8.19 | -8.41 | -8.40 | 29.02% | CHEMBL4068003 |
TNFA_HUMAN | tumor necrosis factor | -7.75 | N/A | N/A | 47.83% | CHEMBL3806296 |
TRBM_HUMAN | thrombomodulin | -7.85 | -7.82 | N/A | N/A | N/A |
TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.30 | -8.34 | N/A | N/A | N/A |
TRPM8_FICAL | Uncharacterized protein | -10.08 | N/A | N/A | N/A | N/A |
TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -8.97 | N/A | N/A | 41.43% | CHEMBL3911358 |
TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.88 | -8.20 | N/A | N/A | N/A |
TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -6.92 | -6.90 | N/A | 38.56% | CHEMBL3949939 |
TRXR1_HUMAN | thioredoxin reductase 1 | -8.67 | -7.76 | -7.35 | N/A | N/A |
TRY1_HUMAN | serine protease 1 | -6.84 | N/A | N/A | 41.67% | CHEMBL138709 |